2.04
Bio Key International Inc stock is traded at $2.04, with a volume of 170.91K.
It is down -18.07% in the last 24 hours and down -31.31% over the past month.
BIO-key International Inc is a identity and access management (IAM) platform provider enabling secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and high-quality, low-cost accessory fingerprint scanner and FIDO-compliant hardware to provide a full and complete solution for identity-innovating customers. The company operates as one operating segment. Its solutions are Passwordless Authentication, Secure Roving Employees, Education, Financial Services, Government, Healthcare, Manufacturing, etc.
See More
Previous Close:
$2.49
Open:
$2.3701
24h Volume:
170.91K
Relative Volume:
2.01
Market Cap:
$2.93M
Revenue:
$6.63M
Net Income/Loss:
$-4.06M
P/E Ratio:
-0.3695
EPS:
-5.5206
Net Cash Flow:
$-4.20M
1W Performance:
-20.47%
1M Performance:
-31.31%
6M Performance:
-39.24%
1Y Performance:
-45.98%
Bio Key International Inc Stock (BKYI) Company Profile
Name
Bio Key International Inc
Sector
Industry
Phone
(732) 359-1100
Address
101 CRAWFORDS CORNER RD, HOLMDEL
Compare BKYI vs MSFT, PLTR, ORCL, CRWD, FTNT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
BKYI
Bio Key International Inc
|
2.04 | 2.93M | 6.63M | -4.06M | -4.20M | -5.5206 |
|
MSFT
Microsoft Corp
|
497.93 | 3.70T | 318.27B | 125.22B | 72.92B | 16.79 |
|
PLTR
Palantir Technologies Inc
|
192.59 | 462.81B | 5.22B | 2.29B | 2.69B | 0.8876 |
|
ORCL
Oracle Corp
|
139.54 | 421.93B | 67.36B | 17.31B | -23.69B | 5.8248 |
|
CRWD
Crowdstrike Holdings Inc
|
259.67 | 265.89B | 5.09B | -24.89M | 1.43B | -0.0471 |
|
FTNT
Fortinet Inc
|
178.67 | 131.09B | 7.11B | 1.95B | 2.44B | 2.5883 |
Bio Key International Inc Stock (BKYI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-26-21 | Upgrade | Maxim Group | Hold → Buy |
Bio Key International Inc Stock (BKYI) Latest News
12 Information Technology Stocks Moving In Wednesday's After-Market Session - Benzinga
A work badge or shared fingerprint scanner enables phone-free sign-in. BIO-key's system earns full certification. - Stock Titan
BIO-key (BKYI) Slides Another -3.64% — Relief Rally Falters 2026-09-22Gap and Go - siam.in
BIO-key International, Inc.(NasdaqCM: BKYI) added to S&P TMI Index - marketscreener.com
12 Information Technology Stocks Moving In Friday's After-Market Session - Benzinga
BIO-key adjourns annual meeting over warrant share vote - TipRanks
BKYI: Biometric IAM platform accelerates growth amid regulatory demand and global deployments - TradingView
BIO-key to Reconvene Annual Meeting After Insufficient Votes on Warrant Approval - TradingView
Shareholder vote on 1.24M new shares delayed at BIO-key (NASDAQ: BKYI) - Stock Titan
BIO-Key International Inc (BKYI) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
BIO-key International CEO to Participate in Virtual Meetings at H.C. Wainwright’s 28th Annual Global Investment Conference - Quiver Quantitative
BIO-key to Meet Investors at H.C. Wainwright | BKYI Stock News - Stock Titan
BIO-Key International Inc (BKYI) Peer Comparison – Compare with Others - Value Research
BIO-Key International Inc (BKYI) Key Financial Ratios – Valuation, Profitability & More - Value Research
BIO-key (BKYI) Q2 2026 Earnings Call Transcript - The Globe and Mail
KALA BIO: Q2 Earnings Snapshot - AOL.com
BIO-key International (BKYI)Conferencia de resultados del T2 de 2026: margen bruto del 87 %, objetivo de rentabilidad para el segundo semestre - TradingKey
BIO-key partners with Central Bank of Jordan to modernize authentication - scanx.trade
BIO-key International (BKYI) Teleconferência de Resultados do T2 de 2026: Margem Bruta de 87%, Meta de Lucratividade para o Segundo Semestre - TradingKey
BIO-key International Inc (BKYI) (Q2 2026) Earnings Call Highlig - GuruFocus
BIO-key International Reports Narrower Loss for Q2 FY26; Revenue up 13% - AlphaStreet
BIO-key International (BKYI) asks investors to approve 1.24M-share warrant issuance - Stock Titan
BIO-key International | PRE 14A: Preliminary proxy statements relating to merger or acquisition - Moomoo
BKYI Q2 FY2026 earnings call - finance.biggo.com
BIO-key International (BKYI) Q2 2026 Earnings Call: 87 % Bruttomarge, Profitabilitätsziel für das zweite Halbjahr - TradingKey
BIO-key International (BKYI) Q2 2026 Earnings Call: 87% Gross Margin, Second-Half Profitability Target - TradingKey
BIO-key International Releases Q2 2026 Financial Results - AlphaStreet
BIO-key International Q2 2026 Earnings Call Transcript - MarketBeat
BKYI: Record gross margin and strong EMEA growth drive improved results and positive H2 outlook - TradingView
Earnings call transcript: BIO-key beats q2 2026 EPS but misses revenue as shares fall - Investing.com Australia
BKYI: Q2 2026 delivered strong margin gains and revenue growth, with profitability targeted for H2 - TradingView
BIO-key International Reports Q2 2026 Results: Full Earnings Call Transcript - Benzinga
Form 8K BIO-Key International Inc For: 14 August By Investing.com - Investing.com Australia
BIO-key International, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
BIO-key Q2 Revenue Rises 13% as Net Loss Narrows 51% - Quiver Quantitative
BIO Key International Q2’26: Revenues up 13% to $1.92M; net loss narrowed 51% - TradingView
BIO-key International (NASDAQ: BKYI) grows Q2 sales and cuts loss sharply - Stock Titan
BIO-key Q2 Loss Narrows to $576,852 Despite Cash Reserve Decline - Minichart
BKYI Looks 49.6% Overvalued on GF Value™ - GuruFocus
BIO-key International Inc (BKYI) (Q2 2026) Earnings Call Highlights: License Revenue Surges 53% ... By GuruFocus - Investing.com Canada
BKYI: Q2'26 revenue up 13%, net loss down 51%, with strong EMEA growth and improved margins - TradingView
BIO-key Q2 revenue up 13%, net loss down 51% on margin expansion - scanx.trade
BIO-key reports Q2 revenue up 13%, narrows net loss by 51% - Investing.com Australia
Form 8K BIO-Key International Inc For: 13 August By Investing.com - Investing.com Nigeria
Bio-key International reduces warrant exercise price in agreement with investor By Investing.com - Investing.com Canada
BIO-key’s Bottom Line Improves 51% on 13% Rise in Q2 Revenues Reflecting Strength with Government, Defense, and Financial Sector Customers Globally; Call Tomorrow at 10am ET - The Manila Times
BIO-key Raises $2.51 Million via Warrant Exercise; Issues New Warrants, Hires Maxim Group - TradingView
BIO KEY INTERNATIONAL INC 2026: Revenue $1.92M, EPS ($0.56) — 10-Q Summary - TradingView
BIO-key’s Bottom Line Improves 51% on 13% Rise in Q2 - GlobeNewswire
BIO-key International (BKYI) secures $2.51M and issues 1.24M new warrants in financing - Stock Titan
BIO-key (BKYI) grows revenue to $4.1M but warns on going concern, liquidity - Stock Titan
Bio Key International Inc Stock (BKYI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):